<DOC>
	<DOCNO>NCT01981447</DOCNO>
	<brief_summary>The purpose study evaluate safety IV Lacosamide child age 4-35 .</brief_summary>
	<brief_title>IV Lacosamide : The Safety Intravenous Lacosamide</brief_title>
	<detailed_description>The objective study evaluate safety IV Lacosamide child age 4 year 35 year , inclusive unable take oral medication require parenteral administration IV Lacosamide Occasionally , patient age 20 see LeBonheur Children 's Hospital due complexity condition , due long relationship physician . These exception review case case basis approve hospital administrator admission outpatient testing .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Lacosamide</mesh_term>
	<criteria>Patient LAR must sign informed consent Diagnosis partial onset currently uncontrolled Patient must receive antiepileptic drug therapy prior initiation Patient must medical condition parental administration desireable Male female Ages 435 Patient participate study involve IV Lacosamide Patient episode status epilepticus last 3 month Drug history lacosamide pregnant lactating If child bearing age , must pregnancy test Patient participate experimental drug study last 30 day Patients significant active hepatic renal disease . Patients know cardiac disease .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>epilepsy</keyword>
</DOC>